/ /


Apixaban, Warfarin Equally Safe, Study FindsA study found that apixaban is a safe alternative to VKAs for ablation of atrial fibrillation.
New Bleeding Reversal Agent Shows PromiseAndaxanet alfa has shown effectiveness for patients needing hemostasis.
New Anticoagulant Guidelines for Cardiac Surgery ReleasedThree medical groups have issued guidelines for the use of anticoagulants during cardiac surgery.
A DOAC Provides Heparin Alternative to Cancer PatientsThe DOAC edoxaban can replace dalteparin for treating cancer patients with venous thromboembolism.
Protein Shows Promise for Anticoagulation in Chronic Kidney DiseaseA protein called STUB1 may help prevent blood clots in patients with chronic kidney disease without causing bleeding complications.
Pharmacists Must Weigh DOACs’ Benefits Versus RisksDirect oral anticoagulants have expanded treatment options for patients with venous thromboembolisms, but they are not for everyone.
Warfarin Linked to Lower Cancer RiskA large Norwegian cohort study has found that warfarin is associated with a reduced risk of cancer.
DOACs Used in Dialysis Patients, but Little Research Has Been DoneDialysis patients are often treated with direct oral anticoagulants, despite little research in this population.
New Resource Educates about Therapies for DVTA new resource for patients with deep vein thrombosis aims to educate about interventional therapies.
Anticoagulants Linked to Lower Dementia RiskOral anticoagulants are associated with a significant reduction in dementia risk for atrial fibrillation patients.